Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin

Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics

White, T. J., Bruns, T., Lee, S., & Taylor, J. (1990) · PCR Protocols · doi:10.1016/b978-0-12-372180-8.50042-1 · Cited by 36,648 · see citing works

PCR protocols — A guide to methods and applications

(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90186-a · Cited by 11,826 · see citing works

PCR protocols — A guide to methods and applications

U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,750 · see citing works

Clinical and Laboratory Standards Institute

Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092 · see citing works

Infectious Diseases Society of America

Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,305 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434 · see citing works

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida

Pfaller, M. A., & Diekema, D. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.t01-1-00844.x · Cited by 422 · see citing works

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377 · see citing works

Epidemiology of candidemia in Latin America: a laboratory-based survey

Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374 · see citing works

Effect of <i>Candida glabrata FKS1</i> and <i>FKS2</i> Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- <scp>d</scp> -Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323 · see citing works

Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints

Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · see citing works

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196 · see citing works

Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical

Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., Queiroz‐Telles, F., Salles, M. J. C., da Cunha, C. A., Shikanai‐Yasuda, M. A., Moretti, M. L., & Nucci, M. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.02.001 · Cited by 157 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases

Ullmann, A. J., Cornely, O. A., DonneNy, J. P., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12037 · Cited by 150 · see citing works

<i>FKS</i> Mutations and Elevated Echinocandin MIC Values among <i>Candida glabrata</i> Isolates from U.S. Population-Based Surveillance

Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136 · see citing works

Caspofungin-Resistant Candida tropicalis Strains Causing Breakthrough Fungemia in Patients at High Risk for Hematologic Malignancies

García‐Effrón, G., Kontoyiannis, D. P., Lewis, R. E., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00802-08 · Cited by 129 · see citing works

Low Prevalence of <i>fks1</i> Hot Spot 1 Mutations in a Worldwide Collection of <i>Candida</i> Strains

Castanheira, M., Woosley, L. N., Diekema, D. J., Messer, S. A., Jones, R. N., & Pfaller, M. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01711-09 · Cited by 125 · see citing works

Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species

García‐Effrón, G., Chua, D. J., Tomada, J. R. T., DiPersio, J. R., Perlin, D. S., Ghannoum, M. A., & Bonilla, H. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00998-09 · Cited by 104 · see citing works

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?

Carlet, J. M., & Mainardi, J. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03702.x · Cited by 61 · see citing works

Candida glabrata : an emerging pathogen in Brazilian tertiary care hospitals

Colombo, A. L., Garnica, M. M., Camargo, L. F. A., da Cunha, C. A., Bandeira, A. C., Borghi, D. P., Campos, T., Senna, A. L., Didier, M. E. V., Dias, V. C., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2012.698024 · Cited by 57 · see citing works

Is the incidence of candidemia caused byCandida glabrataincreasing in Brazil? Five-year surveillance ofCandidabloodstream infection in a university reference hospital in southeast Brazil

Moretti, M. L., Trabasso, P., Lyra, L., Fagnani, R., Resende, M. R., Cardoso, L. G. D. O., & Schreiber, A. Z. (2012) · Medical Mycology · doi:10.3109/13693786.2012.708107 · Cited by 55 · see citing works

Editorial

Raoult, D. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03915.x · Cited by 38 · see citing works

FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy

Costa‐de‐Oliveira, S., Miranda, I. M., Silva, R. M., Silva, A. P., Rocha, R., Amorim, A., Rodrigues, A. G., & Pina‐Vaz, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00589-10 · Cited by 37 · see citing works

Population-Based Surveillance

(2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_6378 · Cited by 34 · see citing works

Accurate Identification of Candida parapsilosis (Sensu Lato) by Use of Mitochondrial DNA and Real-Time PCR

Souza, A. C. R., Ferreira, R. C., Gonçalves, S. S., Quindós, G., Eraso, E., Bizerra, F. C., Briones, M. R. S., & Colombo, A. L. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00303-12 · Cited by 33 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Healey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · see citing works

Role of FKS mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance

Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · see citing works

Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

Cornely, O. A., Hoenigl, M., Lass‐Flörl, C., Chen, S. C. ‐., Kontoyiannis, D. P., Morrissey, C. O., & Thompson, G. R. (2019) · Mycoses · doi:10.1111/myc.12960 · Cited by 225 · see citing works

Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program

Doi, A. M., Pignatari, A. C. C., Edmond, M. B., Marra, A. R., Camargo, L. F. A., Siqueira, R. A., da Mota, V. P., & Colombo, A. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146909 · Cited by 219 · see citing works

Invasive candidiasis: current clinical challenges and unmet needs in adult populations

Soriano, À., Honoré, P. M., Puerta‐Alcalde, P., García‐Vidal, C., Pagotto, A., Gonçalves, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 201 · see citing works

Breakthrough invasive fungal infections: Who is at risk?

Jenks, J. D., Cornely, O. A., Chen, S. C. ‐., Thompson, G. R., & Hoenigl, M. (2020) · Mycoses · doi:10.1111/myc.13148 · Cited by 191 · see citing works

Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus

Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F. G. M., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 182 · see citing works

Emerging multidrug-resistant Candida species

Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177 · see citing works

Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?

Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 135 · see citing works

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109 · see citing works

Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers

da Matta, D. A., Souza, A. C. R., & Colombo, A. L. (2017) · Journal of Fungi · doi:10.3390/jof3020024 · Cited by 105 · see citing works

Review on Current Status of Echinocandins Use

Mroczyńska, M., & Brillowska‐Dąbrowska, A. (2020) · Antibiotics · doi:10.3390/antibiotics9050227 · Cited by 108 · see citing works

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works

Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-d-glucan

Nucci, M., Nouér, S. A., Esteves, P., Guimarães, T., Breda, G. L., de Miranda, B. G., Queiroz‐Telles, F., & Colombo, A. L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw188 · Cited by 67 · see citing works

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

Bailly, S., Leroy, O., Montravers, P., Constantin, J., Dupont, H., Guillemot, D., Lortholary, O., Mira, J. P., Pérrigault, P.-F., Gangneux, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4053-1 · Cited by 64 · see citing works

Semisynthesis and Biological Evaluation of Xanthone Amphiphilics as Selective, Highly Potent Antifungal Agents to Combat Fungal Resistance

Lin, S., Sin, W. L. W., Koh, J.-J., Lim, F., Wang, L., Cao, D., Beuerman, R. W., Ren, L., & Liu, S. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01348 · Cited by 54 · see citing works

Set of Classical PCRs for Detection of Mutations in <i>Candida glabrata FKS</i> Genes Linked with Echinocandin Resistance

Dudiuk, C., Gamarra, S., Leonardeli, F., Jimenez-Ortigosa, C., Vitale, R. G., Afeltra, J., Perlin, D. S., & Garcia-Effron, G. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01038-14 · Cited by 50 · see citing works

Candida glabrata – unique features and challenges in the clinical management of invasive infections

Glöckner, A., & Cornely, O. A. (2015) · Mycoses · doi:10.1111/myc.12348 · Cited by 49 · see citing works

Potential of Gallium as an Antifungal Agent

Bastos, R., Rossato, L., Valero, C., Lagrou, K., Colombo, A., & Goldman, G. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00414 · Cited by 47 · see citing works

Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: Molecular Characterization

Rivero-Menéndez, O., Navarro-Rodríguez, P., Bernal‐Martínez, L., Martin-Cano, G., Lopez-Perez, L., Sánchez‐Romero, I., Pérez‐Ayala, A., Capilla, J., Zaragoza, Ó., & Alastruey‐Izquierdo, A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01585 · Cited by 45 · see citing works

Novel <i>FKS1</i> and <i>FKS2</i> modifications in a high-level echinocandin resistant clinical isolate of <i>Candida glabrata</i>

Hou, X., Healey, K. R., Shor, E., Kordalewska, M., Ortigosa, C. J., Paderu, P., Xiao, M., Wang, H., Zhao, Y., Lin, L.-Y., et al. (2019) · Emerging Microbes &amp; Infections · doi:10.1080/22221751.2019.1684209 · Cited by 43 · see citing works

Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries

Arastehfar, A. A., Daneshnia, F., Kord, M., Roudbary, M., Zarrinfar, H., Fang, W., Hashemi, S. J., Najafzadeh, M. J., Khodavaisy, S., Pan, W., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00021 · Cited by 45 · see citing works

Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multicenter Study in China

Hou, X., Xiao, M., Wang, H., Yu, S.-Y., Zhang, G., Zhao, Y., & Xu, Y. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-18 · Cited by 40 · see citing works

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

Gioia, F., Gómez‐López, A., Alvarez, M. E., de la Pedrosa, E. G., Martín‐Dávila, P., Cuenca‐Estrella, M., Moreno, S., & Fortün, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.019 · Cited by 40 · see citing works

Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin

Oliva, A., Rosa, F. G. D., Mikulska, M., Pea, F., Sanguinetti, M., Tascini, C., & Venditti, M. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2240956 · Cited by 40 · see citing works

Raman Spectroscopy of Oral Candida Species: Molecular-Scale Analyses, Chemometrics, and Barcode Identification

Pezzotti, G., Kobara, M., Nakaya, T., Imamura, H., Miyamoto, N., Adachi, T., Yamamoto, T., Kanamura, N., Ohgitani, E., Marin, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105359 · Cited by 37 · see citing works

Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital

Kimura, M., Araoka, H., Yamamoto, H., Asano‐Mori, Y., Nakamura, S., Yamagoe, S., Ohno, H., Miyazaki, Y., Abe, M., Yuasa, M., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01791-16 · Cited by 30 · see citing works

Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs

Rodrigues, C. F., & Henriques, M. (2018) · Genes · doi:10.3390/genes9040205 · Cited by 29 · see citing works

The epidemiology of invasive fungal infections in transplant recipients

Mahmoud, D. E., Hérivaux, A., Morio, F., Briard, B., Vigneau, C. M., Désoubeaux, G., Bouchara, J., Gangneux, J., Nevez, G., Gal, S. L., et al. (2024) · Biomedical Journal · doi:10.1016/j.bj.2024.100719 · Cited by 33 · see citing works

Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study

Breda, G. L., Tuon, F. F., Meis, J. F. G. M., Herkert, P. F., Hagen, F., de Oliveira, L. Z., Dias, V. D. C., da Cunha, C. A., & Queiroz‐Telles, F. (2017) · Medical Mycology · doi:10.1093/mmy/myx077 · Cited by 27 · see citing works

Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment

Fraser, M., Borman, A. M., Thorn, R. M. S., & Lawrance, L. M. (2019) · Medical Mycology · doi:10.1093/mmy/myz053 · Cited by 26 · see citing works

Clinical and epidemiological aspects of Candidemia in eight medical centers in the state of Parana, Brazil: Parana Candidemia Network

de Oliveira, C. S., Colombo, A. L., Francisco, E. C., de Lima, B., Gandra, R. F., de Carvalho, M. C. P., Carrilho, C. M. D. D. M., Petinelli, R. P., Pelisson, M., Helbel, C., et al. (2020) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2020.11.006 · Cited by 26 · see citing works

Catheter-related candidemia and identification of causative Candida species in patients with cardiovascular disorder

Fesharaki, S. H., Âghili, S. R., Shokohi, T., & Boroumand, M. A. (2018) · Current Medical Mycology · doi:10.18502/cmm.4.2.63 · Cited by 24 · see citing works

A Noncanonical DNA Damage Checkpoint Response in a Major Fungal Pathogen

Shor, E., Garcia‐Rubio, R., DeGregorio, L., & Perlin, D. S. (2020) · mBio · doi:10.1128/mbio.03044-20 · Cited by 23 · see citing works

Hotspot gene conversion between FKS1 and FKS2 in echinocandin resistant Candida glabrata serial isolates

Zajac, C., Scott, N. E., Kline, S., Erayil, S. E., & Selmecki, A. M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00102-6 · Cited by 19 · see citing works

Biological Characterization and in Vivo Assessment of the Activity of a New Synthetic Macrocyclic Antifungal Compound

Deodato, D., Maccari, G., Luca, F. D., Sanfilippo, S., Casian, A., Martini, R., D’Arezzo, S., Bonchi, C., Bugli, F., Posteraro, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00018 · Cited by 20 · see citing works

Risk Factors and Outcomes of Recurrent Candidemia in Children: Relapse or Re-Infection?

Lai, M., Hsu, J., Chu, S., Wu, I.-H., Huang, H., Chiang, M., Fu, R.-H., & Tsai, M.-H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010099 · Cited by 19 · see citing works

Discontinuation of echinocandin and azole treatments led to the disappearance of an FKS alteration but not azole resistance during clonal Candida glabrata persistent candidaemia

Imbert, S., Castain, L., Pons, A., Jacob, S., Meyer, I., Palous, M., Vézinet, C., Langeron, O., Hennequin, C., Monsel, A., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.07.025 · Cited by 18 · see citing works

Breakthrough Candidemia in Children: Clinical and Microbiological Characteristics, Therapeutic Strategies and Impact on Outcomes

Lai, M., Hsu, J., Chu, S., Wu, I.-H., Huang, H., Lin, C., Lee, I., Chiang, M., Fu, R.-H., & Tsai, M.-H. (2017) · Future Microbiology · doi:10.2217/fmb-2016-0223 · Cited by 17 · see citing works

Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies

Madney, Y., Shalaby, L., ElAnany, M. G., Adel, N., Nasr, E. M. E. M., Alsheshtawi, K., Younes, A., & Hafez, H. (2019) · Mycoses · doi:10.1111/myc.13002 · Cited by 17 · see citing works

Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study

Giannella, M., Paolucci, M., Roncarati, G., Vandi, G., Pascale, R., Trapani, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R. E., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky247 · Cited by 17 · see citing works

Whole-Genome Sequence Analysis of Candida glabrata Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance

Lim, H. J., Choi, M. J., Byun, S. A., Won, E. J., Park, J.-H., Choi, Y. J., Choi, H., Choi, H.-W., Kee, S., Kim, S. H., et al. (2023) · Journal of Fungi · doi:10.3390/jof9050515 · Cited by 15 · see citing works

Molecular Analysis of Resistance and Detection of Non-Wild-Type Strains Using Etest Epidemiological Cutoff Values for Amphotericin B and Echinocandins for Bloodstream Candida Infections from a Tertiary Hospital in Qatar

Taj‐Aldeen, S. J., Salah, H., Perez, W. B., AlMaslamani, M. A. R. S., Motyl, M. R., AbdulWahab, A., Healey, K. R., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00214-18 · Cited by 16 · see citing works

Predicting candidemia in the internal medicine wards: a comparison with gram-negative bacteremia—a retrospectives study

Atamna, A., Eliakim‐Raz, N., Mohana, J., Ben‐Zvi, H., Sorek, N., Shochat, T., & Bishara, J. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.04.007 · Cited by 16 · see citing works

Antifungal Susceptibility Patterns ofCandidaSpecies Recovered from Endotracheal Tube in an Intensive Care Unit

Baghdadi, E., Khodavaisy, S., Rezaie, S., Abolghasem, S., Kiasat, N., Salehi, Z., Sharifynia, S., & Aala, F. (2016) · Advances in Medicine · doi:10.1155/2016/9242031 · Cited by 15 · see citing works

Species Distribution of Candidemia and Their Susceptibility in a Single Japanese University Hospital: Prior Micafungin Use Affects the Appearance of Candida parapsilosis and Elevation of Micafungin MICs in Non-parapsilosis Candida Species

Sakamoto, Y., Kawabe, K., Suzuki, T., Sano, K., Ide, K., Nishigaki, T., Enoki, Y., Taguchi, K., Koike, H., Kato, H., et al. (2021) · Journal of Fungi · doi:10.3390/jof7080596 · Cited by 16 · see citing works

In vitro susceptibility and molecular characterization of Candida spp. from candidemic patients

Herkert, P. F., Gomes, R. R., Muro, M. D., Pinheiro, R. L., Fornari, G., Vicente, V. A., & Queiroz‐Telles, F. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2014.07.007 · Cited by 14 · see citing works

The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus

Ostrosky‐Zeichner, L., & Andes, D. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix239 · Cited by 13 · see citing works

Inflammatory Cell Recruitment in Candida glabrata Biofilm Cell-Infected Mice Receiving Antifungal Chemotherapy

Rodrigues, C. F., Correia, A., Vilanova, M., & Henriques, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020142 · Cited by 15 · see citing works

Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: A systematic review and meta‐analysis

Bienvenu, A., Leboucher, G., & Picot, S. (2019) · Mycoses · doi:10.1111/myc.12929 · Cited by 12 · see citing works

DNA damage response of major fungal pathogen Candida glabrata offers clues to explain its genetic diversity

Shor, E., & Perlin, D. S. (2021) · Current Genetics · doi:10.1007/s00294-021-01162-7 · Cited by 12 · see citing works

Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato‐oncological high‐risk patients: a web‐based non‐interventional trial in four large university hospitals in G ermany

Heimann, S. M., Vehreschild, M. J. G. T., Meintker, L., Heinz, W., Schroeder, T. A., von Bergwelt‐Baildon, M., Cornely, O. A., & Vehreschild, J. J. (2014) · Transplant Infectious Disease · doi:10.1111/tid.12305 · Cited by 10 · see citing works

Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients

Hrabovský, V., Takáčová, V., Schréterová, E., Pastvová, L., Hrabovská, Z., Čurová, K., & Siegfried, L. (2017) · Folia Microbiologica · doi:10.1007/s12223-017-0525-8 · Cited by 10 · see citing works

Antifungal Stewardship in Low- and Middle-Income Countries

Riera, F. O., Caeiro, J. P., & Sotomayor, C. E. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00197-2 · Cited by 8 · see citing works

Current trends in outwitting resistance development inCandidainfections through photodynamic and short peptide therapies: a strategic-shift from conventional antifungal agents

Louis, B., Waikhom, S. D., & Atadja, P. W. (2016) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2016.1147953 · Cited by 7 · see citing works

Challenges in management of invasive fungal infections in stem cell transplant

Walker, J. B., Edwards, S., Hall, N. M., & Pappas, P. G. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14175 · Cited by 4 · see citing works

Multidrug- and Cross-Resistant Candida: the Looming Threat

Lackner, M., Martín‐Vicente, A., & Lass‐Flörl, C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0210-1 · Cited by 4 · see citing works

The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections

Veselov, A. V. (2020) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2020.3.197-209 · Cited by 6 · see citing works

In Vitro Determination of Hydrolytic Enzymes and Echinocandin Susceptibility in Mexican Clinical Isolates of Candida glabrata Sensu Stricto

Treviño‐Rangel, R. D. J., Espinosa-Pérez, J. F., Villanueva‐Lozano, H., Soto-Quintana, L. A., Montoya, A. M., Luna-Rodríguez, C. E., & González, G. M. (2019) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.85092 · Cited by 2 · see citing works

EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients

Llinares, P., Ruíz-Camps, I., Zaragoza, R., Ferrer, R., Rodríguez, A. H., Maseda, E., & Grau, S. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.06.002 · Cited by 1 · see citing works

Echinocandin Resistance

Perlin, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-46718-4_29

Estudo sentinela: monitoramento da colonização fúngica de mucosa oral em crianças internadas em Hospital Público, São Paulo

Ramos, R. T. B. (2023) · doi:10.11606/t.23.2023.tde-29042024-104049

Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

Saraya, T., Tanabe, K., Araki, K., Yonetani, S., Makino, H., Watanabe, T., Tsujimoto, N., Takata, S., Kurai, D., Ishii, H., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03593-13 · Cited by 22 · see citing works

Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure

Lewis, J. S., Wiederhold, N. P., Wickes, B. L., Patterson, T. F., & Jorgensen, J. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01144-13 · Cited by 101 · see citing works

<i>FKS</i> Mutations and Elevated Echinocandin MIC Values among <i>Candida glabrata</i> Isolates from U.S. Population-Based Surveillance

Zimbeck, A. J., Iqbal, N., Ahlquist, A. M., Farley, M. M., Harrison, L. H., Chiller, T., & Lockhart, S. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00836-10 · Cited by 136 · see citing works

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196 · see citing works

Recurrent echinocandin-resistant Candida glabrata candidemia following prolonged micafungin treatment of multiple intra-abdominal abscesses

Zhou, H., & Fuller, J. (2018) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi.3.1.09